Cargando…
Th17 Cells as Potential Probiotic Therapeutic Targets in Inflammatory Bowel Diseases
Inflammatory bowel diseases (IBD) are characterized by wasting and chronic intestinal inflammation triggered by various cytokine-mediated pathways. In recent years, it was shown that T helper 17 (Th17) cells are involved in the pathogenesis of IBD, which makes them an attractive therapeutic target....
Autores principales: | Owaga, Eddy, Hsieh, Rong-Hong, Mugendi, Beatrice, Masuku, Sakhile, Shih, Chun-Kuang, Chang, Jung-Su |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4613231/ https://www.ncbi.nlm.nih.gov/pubmed/26340622 http://dx.doi.org/10.3390/ijms160920841 |
Ejemplares similares
-
Inflammatory Bowel Disease Therapeutics: A Focus on Probiotic Engineering
por: Mishra, Jayshree, et al.
Publicado: (2022) -
Nutritional Knowledge, Attitude, and Practices among Pregnant and Lactating Women Living with HIV in the Manzini Region of Swaziland
por: Masuku, Sakhile K.S., et al.
Publicado: (2014) -
Th17 Cells in Inflammatory Bowel Disease: Cytokines, Plasticity, and Therapies
por: Zhao, Junjun, et al.
Publicado: (2021) -
The role of Th17 cells in inflammatory bowel disease and the research progress
por: Chen, Lu, et al.
Publicado: (2023) -
The Function and Role of the Th17/Treg Cell Balance in Inflammatory Bowel Disease
por: Yan, Jun-bin, et al.
Publicado: (2020)